35 U.S.C. 101 – USPTO Issues guidelines for examiners on what is patentable subject matter
The recent AMP v Myriad decision1 (‘Myriad’) in the United States Supreme Court explored subject matter excluded from patentability in the US. The Court held that a naturally occurring segment of DNA is a product of nature and is not eligible for patentability merely because it has been isolated. How the United States Patent and …
>> Read more